T. D. Blagg and . Kerr, Hsp90 inhibitors: small molecules that transform the Hsp90 protein folding machinery into a catalyst for protein degradation, Med. Res. Rev, pp.26-310, 2006.

A. Donnelly and B. S. Blagg, Novobiocin and additional inhibitors of the Hsp90 Cterminal nucleotide-binding pocket, Curr. Med. Chem, pp.15-2702, 2008.

L. Neckers and P. Workman, Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?, Clinical Cancer Research, vol.18, issue.1, pp.64-76, 2012.
DOI : 10.1158/1078-0432.CCR-11-1000

L. Whitesell, S. Santagata, and N. U. Lin, Inhibiting HSP90 to Treat Cancer: A Strategy in Evolution, Current Molecular Medicine, vol.12, issue.9, pp.12-1108, 2012.
DOI : 10.2174/156652412803306657

L. B. Peterson and B. S. Blagg, To fold or not to fold: modulation and consequences of Hsp90 inhibition, Future Medicinal Chemistry, vol.1, issue.2, 2009.
DOI : 10.4155/fmc.09.17

H. Zhao and B. S. Blagg, Inhibitors of the Hsp90 C-terminus, Inhibitors of Molecular Chaperones as Therapeutic Agents

M. G. Marcu, T. W. Schulte, and L. Neckers, Novobiocin and Related Coumarins and Depletion of Heat Shock Protein 90-Dependent Signaling Proteins, JNCI: Journal of the National Cancer Institute, vol.92, issue.3, pp.92-242, 2000.
DOI : 10.1093/jnci/92.3.242

S. M. Roe, C. Prodromou, R. O-'brien, J. E. Ladbury, P. W. Piper et al., Structural Basis for Inhibition of the Hsp90 Molecular Chaperone by the Antitumor Antibiotics Radicicol and Geldanamycin, Journal of Medicinal Chemistry, vol.42, issue.2, p.42, 1999.
DOI : 10.1021/jm980403y

R. K. Allan, D. Mok, B. K. Ward, and T. Ratajczak, Modulation of Chaperone Function and Cochaperone Interaction by Novobiocin in the C-terminal Domain of Hsp90, Journal of Biological Chemistry, vol.281, issue.11, pp.281-7161, 2006.
DOI : 10.1074/jbc.M512406200

X. M. Yu, G. Shen, L. Neckers, H. Blake, J. Holzbeierlein et al., Hsp90 Inhibitors Identified from a Library of Novobiocin Analogues, Journal of the American Chemical Society, vol.127, issue.37, pp.12778-12779, 2005.
DOI : 10.1021/ja0535864

J. A. Burlison, C. Avila, G. Vielhauer, D. J. Lubbers, J. Holzbeierlein et al., Development of Novobiocin Analogues That Manifest Anti-proliferative Activity against Several Cancer Cell Lines, The Journal of Organic Chemistry, vol.73, issue.6, pp.73-2130, 2008.
DOI : 10.1021/jo702191a

H. Zhao, A. C. Donnelly, B. R. Kusuma, G. E. Brandt, D. Brown et al., Engineering an Antibiotic to Fight Cancer: Optimization of the Novobiocin Scaffold to Produce Anti-proliferative Agents, Journal of Medicinal Chemistry, vol.54, issue.11, p.54, 2011.
DOI : 10.1021/jm200148p

H. Zhao, B. R. Kusuma, and B. S. Blagg, Synthesis and Evaluation of Noviose Replacements on Novobiocin That Manifest Antiproliferative Activity, ACS Medicinal Chemistry Letters, vol.1, issue.7, pp.311-315, 2010.
DOI : 10.1021/ml100070r

H. Zhao and B. S. Blagg, Novobiocin analogues with second-generation noviose surrogates, Bioorganic & Medicinal Chemistry Letters, vol.23, issue.2, pp.552-557, 2013.
DOI : 10.1016/j.bmcl.2012.11.022

H. Zhao, E. Moroni, B. Yan, G. Colombo, and B. S. Blagg, 3D-QSAR-Assisted Design, Synthesis, and Evaluation of Novobiocin Analogues, ACS Medicinal Chemistry Letters, vol.4, issue.1, pp.57-62, 2013.
DOI : 10.1021/ml300275g

H. Zhao, E. Moroni, G. Colombo, and B. S. Blagg, Identification of a New Scaffold for Hsp90 C-Terminal Inhibition, ACS Medicinal Chemistry Letters, vol.5, issue.1, pp.84-88, 2014.
DOI : 10.1021/ml400404s

H. Zhao, G. Garg, J. Zhao, E. Moroni, A. Girgis et al., Design, synthesis and biological evaluation of biphenylamide derivatives as Hsp90??C-terminal inhibitors, European Journal of Medicinal Chemistry, vol.89, pp.442-466, 2015.
DOI : 10.1016/j.ejmech.2014.10.034

G. Garg, H. Zhao, and B. S. Blagg, Design, Synthesis, and Biological Evaluation of Ring-Constrained Novobiocin Analogues as Hsp90 C-Terminal Inhibitors, ACS Medicinal Chemistry Letters, vol.6, issue.2, 2015.
DOI : 10.1021/ml5004475

G. , L. Bras, C. Radanyi, J. Peyrat, J. Brion et al., New novobiocin analogues as antiproliferative agents in breast cancer cells and potential inhibitors of heat shock protein 90, J. Med. Chem, pp.50-6189, 2007.

C. Radanyi, G. Le-bras, V. Marsaud, J. Peyrat, S. Messaoudi et al., Antiproliferative and apoptotic activities of tosylcyclonovobiocic acids as potent heat shock protein 90 inhibitors in human cancer cells, Cancer Letters, vol.274, issue.1, pp.88-94, 2009.
DOI : 10.1016/j.canlet.2008.09.001

D. Audisio, S. Messaoudi, L. Cegielkowski, J. Peyrat, J. Brion et al., Discovery and Biological Activity of 6BrCaQ as an Inhibitor of the Hsp90 Protein Folding Machinery, ChemMedChem, vol.306, issue.5, pp.804-816, 2011.
DOI : 10.1002/cmdc.201000489

D. Audisio, D. Methy-gonnot, C. Radanyi, J. Renoir, S. Denis et al., Synthesis and antiproliferative activity of novobiocin analogues as potential hsp90 inhibitors, Synthesis and antiproliferative activity of novobiocin analogues as potential Hsp90 inhibitors, pp.498-507, 2014.
DOI : 10.1016/j.ejmech.2014.06.067

R. M. Cross and R. Manetsch, Divergent route to access structurally diverse 4- quinolones via mono or sequential cross-couplings, J. Org. Chem, pp.75-8654, 2010.

D. Montoir, A. Tonnerre, M. Duflos, and M. Bazin, Differential functionalization of 1,6-naphthyridin-2(1H)-ones through sequential one-pot Suzuki-Miyaura cross couplings, Eur. J. Org. Chem, vol.7, pp.1487-1495, 2014.

D. Montoir, A. Tonnerre, M. Duflos, and M. Bazin, Efficient one-pot synthesis of 3,7-disubstituted 1,6-naphthyridin-2(1H)-ones through regioselective palladium-catalyzed cross-coupling and SNAr reactions, Tetrahedron, vol.71, 2015.

M. J. Matos, F. Rodríguez-enríquez, F. Borges, L. Santana, E. Uriarte et al., Vi~ na, 3-Amidocoumarins as potential multifunctional agents against neurodegenerative diseases, ChemMedChem, vol.10, 2015.

M. Dreyer, A. Hofmeister, Y. Ivashchenko, D. Kadereit, A. Kannt et al., Isoquinoline derivatives as inhibitors of rho-kinase, PCT Int, Appl. WO, 2005.

A. Kamal, L. Thao, J. Sensintaffar, L. Zhang, M. F. Boehm et al., A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors, Nature, vol.425, issue.6956, pp.425-407, 2003.
DOI : 10.1038/nature01913

P. Tran, S. A. Kim, H. S. Choi, J. H. Yoon, and S. G. Ahn, Epigallocatechin-3-gallate suppresses the expression of HSP70 and HSP90 and exhibits anti-tumor activity in vitro and in vivo, BMC Cancer, vol.79, issue.1, p.276, 2010.
DOI : 10.1002/(SICI)1097-0215(19981023)79:5<468::AID-IJC4>3.0.CO;2-Z

P. W. Elsinghorst, J. S. Cieslik, K. Mohr, C. Tr?-ankle, and M. Gütschow, First gallaminetacrine hybrid: design and characterization at cholinesterases and the M2 muscarinic receptor, J. Med. Chem, pp.50-5685, 2007.

K. W. Anderson and S. L. Buchwald, General catalysts for the Suzuki-Miyaura and Sonogashira coupling reactions of aryl chlorides and for the coupling of challenging substrate combinations in water, Angew. Chem. Int. Ed, pp.44-6173, 2005.